Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB261941594

Follistatin Antibody (17-2), DyLight 594, Novus Biologicals™
SDP

Catalog No. NB261941594 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB261941594 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB261941594 Supplier Novus Biologicals Supplier No. NBP261941DL594

Description

Mouse Monoclonal Antibody

Follistatin Monoclonal specifically detects Follistatin in Human samples. It is validated for Western Blot, ELISA, Immunohistochemistry.

Specifications

Antigen Follistatin
Applications ELISA, Immunohistochemistry, Western Blot
Classification Monoclonal
Clone 17-2
Conjugate DyLight 594
Dilution Western Blot, ELISA, Immunohistochemistry
Formulation PBS with 0.05% Sodium Azide
Gene Alias follistatin, follistatin isoform FST317, FSActivin-binding protein
Gene Symbols FST
Host Species Mouse
Immunogen Recognizes human Follistatin isoform FS288, raised against recombinant human FS288
Purification Method Protein A purified
Quantity 0.1 mL
Research Discipline Cancer
Primary or Secondary Primary
Gene ID (Entrez) 10468
Test Specificity This antibody recognizes human Follistatin isoform FS288.
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.